• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Telephone cognitive behavioral therapy for insomnia in adults With osteoarthritis pain

byJack LennonandAlex Chan
March 17, 2021
in Chronic Disease, Psychiatry
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Telephone cognitive behavioral therapy for insomnia (CBT-I) was an effective treatment for sleep issues among patients with osteoarthritis pain (OA).

2. Fatigue was significantly reduced among the CBT-I group, compared to the education-only group.

3. CBT-I demonstrated evidence of short-term pain reduction, but this was not sustained at 12-month follow-up.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Cognitive behavioral therapy is an effective treatment for insomnia (CBT-I). However, treatment delivery to rural and underserved populations has been limited. Utilizing telephone methods that can be more easily accessed by these groups of people could allow for better treatment and reduced disparities among individuals with insomnia and pain conditions, such as osteoarthritis pain (OA).

This randomized clinical trial of 327 older adults were randomly assigned to be exposed to six 20-30-minute telephone CBT-I sessions or group-specific educational materials. CBT-I was found to improve fatigue and sleep, as well as pain among older adults. Pain reductions did not remain significant at 12-month follow-up, but posttreatment differences in the earlier stages were significant.

Overall, this study demonstrated that telephone CBT-I is an effective treatment for sleep disturbances and fatigue in pain patients, with some evidence for short-term pain reduction. Further, this treatment can be conducted via telephone to reach a broader group of patients in need of care. At a time when virtual healthcare is an important component of treatment, this study confirms that CBT-I is one such treatment that can be effectively delivered through technological means.

RELATED REPORTS

Comprehensive laughter-intervention programs as a means to improve physical and psychological health

Marginalized identities, mistreatment, discrimination, and burnout among US medical students

2 Minute Medicine Rewind April 13, 2022

Click to read the study in JAMA Internal Medicine

Relevant Reading: Cognitive Behavioral Therapy for Insomnia Improves Sleep and Decreases Pain in Older Adults with Co-Morbid Insomnia and Osteoarthritis

In-Depth [ prospective cohort]:

CBT-I has proven effectiveness and this may be extended to individuals with comorbid pain conditions, such as OA. Further, delivering CBT-I via telephone would allow for rural and underserved populations to have greater accessibility to effective treatment. This randomized clinical trial of adults over the age of 60 years with OA and moderate-to-severe insomnia sought to investigate the effectiveness of telephone CBT-I compared to education-only controls (EOC). Participants 60 years of age and older were recruited through Kaiser Permanente Washington between September 2016 and December 2018, being screened twice at least three weeks apart for moderate-to-severe insomnia and OA pain symptoms. Blind assessments of patients in both the CBT-I and EOC groups were conducted at baseline, two months posttreatment, and 12 months posttreatment. Treatment included six 20-30-minute sessions conducted via telephone over eight weeks. While the CBT-I group was educated on sleep restriction, stimulus control, cognitive restructuring, and sleep hygiene, the EOC group only received information about sleep and OA.

Participants were assessed via the Insomnia Severity Index (ISI) at two months and 12 months follow-up. They were also assessed for pain via the Brief Pain Inventory-short form, depression via the Patient Health Questionnaire (8-item), and fatigue via the Flinders Fatigue Scale. Of the 327 older adult participants (M [SD] age = 70.2 [6.8] years, 74.6% female), 282 had follow-up ISI data at the two-month follow-up. The ISI scores decreased in both groups, with CBT-I proving more effective (adjusted mean difference = -3.5 points, 95% CI -4.4 to -2.6, p<.001). These results retained significance at 12-month follow-up (adjusted mean difference = -3.0, 95% CI -4.1 to 02.0, p<.001). Approximately 56.3% of participants in the CBT-I group were still in remission at 12 months, compared to 25.8% of the EOC group. Fatigue was another area of improvement, with CBT-I proving superior in its posttreatment effects at two months (mean difference = -2.0, 95% CI -3.1 to -0.9, p<.001) and 12 months (mean difference = -1.8, 95% CI -3.1 to -.06, p = .003). Lastly, pain was significantly reduced during posttreatment follow-up but these differences between groups did not remain significant at 12-month follow-up.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cognitive behavioral therapy (CBT)psychiatry
Previous Post

#VisualAbstract: Increased albumin infusions did not improve decompensated cirrhosis

Next Post

Donanemab improved cognitive measures in early Alzheimer’s disease

RelatedReports

Few older adolescents meet recommended levels of physical activity
Chronic Disease

Comprehensive laughter-intervention programs as a means to improve physical and psychological health

April 25, 2022
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse
Psychiatry

Marginalized identities, mistreatment, discrimination, and burnout among US medical students

April 25, 2022
Late gestation antidepressant use linked to postpartum hemorrhage
Weekly Rewinds

2 Minute Medicine Rewind April 13, 2022

April 18, 2022
Being overweight and obese associated with increased incidence of chronic kidney disease
Weekly Rewinds

2 Minute Medicine Rewind April 4, 2022

April 4, 2022
Next Post
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress

Donanemab improved cognitive measures in early Alzheimer’s disease

#VisualAbstract: Salpingo-oophorectomy may reduce short-term risk of breast cancer in women with BRCA1 and BRCA2 variants

#VisualAbstract: Salpingo-oophorectomy may reduce short-term risk of breast cancer in women with BRCA1 and BRCA2 variants

Study explores effects of daily iron supplementation in 2- to 5-year-olds

Pegcetacoplan improved hemoglobin levels in eculizumab-treated paroxysmal nocturnal hemoglobinuria patients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.